SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 251 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $102,016,000 | -44.9% | 590,337 | -63.3% | 0.08% | -47.2% |
| Q4 2014 | $185,128,000 | +915.3% | 1,610,648 | +1280.2% | 0.16% | +835.3% |
| Q3 2014 | $18,233,000 | +65.2% | 116,700 | +30.4% | 0.02% | +70.0% |
| Q2 2014 | $11,040,000 | -57.6% | 89,500 | -64.3% | 0.01% | -58.3% |
| Q1 2014 | $26,008,000 | -7.2% | 251,016 | -19.4% | 0.02% | -7.7% |
| Q4 2013 | $28,024,000 | +9.3% | 311,578 | -18.8% | 0.03% | +4.0% |
| Q3 2013 | $25,650,000 | +53.3% | 383,522 | +51.7% | 0.02% | +47.1% |
| Q2 2013 | $16,728,000 | – | 252,888 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 2,787,800 | $481,760,000 | 55.98% |
| Brenner West Capital Advisors | 1,800,000 | $311,058,000 | 28.01% |
| FNY Managed Accounts LLC | 180,357 | $31,167,493,000 | 25.70% |
| Twin Securities, Inc. | 1,189,192 | $205,505,000 | 24.16% |
| FIRST NEW YORK SECURITIES LLC /NY | 98,099 | $16,952,488,000 | 16.70% |
| HARVEST MANAGEMENT LLC | 77,500 | $13,393,000 | 14.40% |
| Tyrus Capital S.A.M. | 687,800 | $118,859,000 | 13.24% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 472,550 | $81,661,000 | 11.65% |
| ARGENTIERE CAPITAL AG | 151,500 | $26,181,000 | 10.81% |
| Sachem Head Capital | 725,000 | $125,425,000 | 8.31% |